Literature DB >> 16473651

Extravasation of chemotherapeutic agents: prevention and treatment.

Tiffany V Goolsby1, Fredric A Lombardo.   

Abstract

Most chemotherapeutic agents can cause varying degrees of local tissue injuries when extravasated. The medical treatment of extravasation is based on proper maintenance of the intravenous (IV) line and application of cold or warm compresses, plus the use of antidotes when available. Antidotes for extravasation that have been shown to be useful are sodium thiosulfate for nitrogen mustard, dimethylsulfoxide for anthracyclines and mitomycin, and hyaluronidase for the vinca alkaloids. New treatments include dexrazoxane, sargramostim, and hyperbaric oxygen for doxorubicin extravasations. Tissue damage secondary to drug infiltration occurs as a result of one of two major mechanisms: (1) the drug is absorbed by local cells in the tissue and binds to critical structures (eg, DNA, microtubules), causing cell death; and (2) the drug does not bind to cellular DNA. Damage to immediately adjacent tissue is more readily neutralized than is damage to surrounding tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473651     DOI: 10.1053/j.seminoncol.2005.11.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  17 in total

1.  Provider Differences in Use of Implanted Ports in Older Adults With Cancer.

Authors:  Allison Lipitz-Snyderman; Elena B Elkin; Coral L Atoria; Camelia S Sima; Andrew S Epstein; Victoria Blinder; Kent A Sepkowitz; Peter B Bach
Journal:  Med Care       Date:  2015-07       Impact factor: 2.983

2.  Drug extravasation: a dreaded complication.

Authors:  Esther Uña; Fernando Cuadrillero; Francisco López-Lara
Journal:  BMJ Case Rep       Date:  2009-04-14

3.  Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey.

Authors:  N LeVasseur; C Stober; M Ibrahim; S Gertler; J Hilton; A Robinson; S McDiarmid; D Fergusson; S Mazzarello; B Hutton; A A Joy; M McInnes; M Clemons
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

Review 4.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

Review 5.  Management of the extravasation of anti-neoplastic agents.

Authors:  J Boulanger; A Ducharme; A Dufour; S Fortier; K Almanric
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

6.  Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study.

Authors:  Hiroki Nagai; Toshiyuki Kitano; Takafumi Nishimura; Hiroyasu Yasuda; Kazumi Nakata; Sachie Takashima; Masashi Kanai; Shigemi Matsumoto; Yukiko Mori; Yuichi Kakudo; Hiroyasu Sato; Takuhiro Yamaguchi; Kaoru Kameno; Young Hak Kim; Michiaki Mishima; Kazuhiro Yanagihara
Journal:  Support Care Cancer       Date:  2013-07-23       Impact factor: 3.603

7.  Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer.

Authors:  Allison Lipitz-Snyderman; Qinli Ma; Michael F Pollack; John Barron; Elena B Elkin; Peter B Bach; Jennifer L Malin
Journal:  J Oncol Pract       Date:  2015-08-11       Impact factor: 3.840

Review 8.  Treatment of anthracycline extravasations using dexrazoxane.

Authors:  D Conde-Estévez; J Mateu-de Antonio
Journal:  Clin Transl Oncol       Date:  2013-08-15       Impact factor: 3.405

Review 9.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Anthracycline extravasation injuries: management with dexrazoxane.

Authors:  Karin Jordan; Timo Behlendorf; Franziska Mueller; Hans-Joachim Schmoll
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.